Bartlett & CO. Wealth Management LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bartlett & CO. Wealth Management LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,839 shares of the medical equipment provider’s stock after selling 80 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,482,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of ISRG. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $38,000. Finally, DT Investment Partners LLC grew its position in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $608.66 on Friday. The business’s fifty day moving average price is $544.61 and its 200 day moving average price is $502.64. The firm has a market capitalization of $216.79 billion, a PE ratio of 97.86, a P/E/G ratio of 5.13 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $616.00.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Raymond James raised their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Finally, Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 42,475 shares of company stock worth $22,070,807. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.